Viatris Inc Ordinary Shares VTRS 深滬

等待開盤 11-26 09:30:00 美东时间

10.56

-0.010

-0.09%

華盛通

立即下載

最高10.73
今開10.60
成交量 694.81万股
最低 10.52
昨收 10.57
總市值 123.97亿
52周最高 12.65
市盈率 ^靜 --
換手率 0.59%
52周最低 6.49
委比 -59.16%
總股本 11.74亿
歷史最高 16.61
量比 0.76
振幅 1.99%
歷史最低 6.49
每手 1
風險率 1.35%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Sol-Gel Technologies announced its Q3 2025 financial results and updates, highlighting progress on its lead drug candidate SGT-610 for Gorlin syndrome with plans to pursue an additional indication for high-frequency basal cell carcinoma (BCC), potentially doubling its commercial potential. The company also secured Health Canada approval for EPSOLAY and signed a new agreement with Viatris for its distribution in Australia and New Zealand. Financia...

11-20 12:30
美股盘后 | Nu Holdings涨3.63%，Atlassian公共涨3.31%

Nu Holdings涨3.63%；Atlassian公共涨3.31%；华纳兄弟探索频道涨3.21%

11-14 07:10
Most S&P 500 healthcare stocks deliver earnings beat this week

21 out of 60 S&P 500 health care companies reported quarterly results this week, of which 20 delivered an earnings beat, and one came in-line with estimates. 16 of the reporting companies exceeded rev...

11-09 10:52
FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma

DARZALEX Faspro® is co-formulated with Halozyme's ENHANZE® drug delivery technology SAN DIEGO, Nov. 7, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announ...

11-07 21:30
Viatris shares are trading lower after the company reported Q3 financial results.

Viatris shares are trading lower after the company reported Q3 financial result...

11-07 01:08
Viatris Q3 Adj. EPS $0.67 Beats $0.62 Estimate, Sales $3.759B Beat $3.609B Estimate

Viatris (NASDAQ:VTRS) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.62 by 7.89 percent. This is a 10.67 percent decrease over earnings of $0.75 per share from the same

11-06 20:04
Earnings Scheduled For November 6, 2025

Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...

11-06 19:12
Lexicon Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides R&D Updates

Lexicon Pharmaceuticals reported Q3 2025 financial results with total revenue increasing to $14.2M, driven by $13.2M in licensing revenue from the Novo Nordisk agreement. R&D expenses decreased to $18.8M, while SG&A expenses fell to $7.6M. The company achieved a net loss of $12.8M compared to $64.8M in Q3 2024. Key milestones include scheduling an End-of-Phase 2 meeting for pilavapadin, completing LX9851 IND-enabling studies, advancing sotagliflo...

11-06 12:30
Teva Pharma's Key Branded Drugs Fuel Strong Revenue Growth, Lifts Full-Year Profit Outlook

Teva Q3 revenue rose to $4.48 billion, beating estimates, as Austedo and Ajovy boosted growth; 2025 EPS outlook now $2.55–$2.65.

11-06 00:30
Viatris Announces Quarterly Dividend

PITTSBURGH, Nov. 4, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that on November 3, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for eac...

11-04 19:59

派息除權日	每股總股息	派息日期
2025-11-24	0.12	2025-12-15
2025-08-22	0.12	2025-09-15
2025-05-23	0.12	2025-06-16
2025-03-10	0.12	2025-03-18
2024-11-22	0.12	2024-12-13
2024-08-23	0.12	2024-09-13
2024-05-23	0.12	2024-06-14
2024-03-08	0.12	2024-03-18
2023-11-22	0.12	2023-12-15
2023-08-23	0.12	2023-09-15
2023-05-23	0.12	2023-06-16
2023-03-08	0.12	2023-03-17
2022-11-22	0.12	2022-12-16
2022-08-23	0.12	2022-09-16
2022-05-23	0.12	2022-06-16
2022-02-23	0.12	2022-03-16
2021-11-22	0.11	2021-12-16
2021-08-23	0.11	2021-09-16
2021-05-21	0.11	2021-06-16
2007-06-27	0.06	2007-07-16
2007-03-28	0.06	2007-04-16
2006-12-27	0.06	2007-01-16
2006-09-27	0.06	2006-10-16
2006-06-28	0.06	2006-07-14
2006-03-29	0.06	2006-04-17
2005-12-28	0.06	2006-01-13
2005-09-28	0.06	2005-10-17
2005-06-28	0.06	2005-07-15
2005-03-29	0.03	2005-04-15
2004-12-29	0.03	2005-01-14
2004-09-28	0.03	2004-10-15
2004-06-28	0.03	2004-07-15
2004-03-29	0.03	2004-04-15
2003-12-29	0.03	2004-01-15
2003-09-26	0.03	2003-10-15
2003-06-26	0.03	2003-07-15
2003-03-27	0.03	2003-04-15
2002-12-27	0.05	2003-01-15
2002-09-26	0.04	2002-10-15
2002-06-26	0.04	2002-07-15
2002-03-26	0.04	2002-04-15
2001-12-27	0.04	2002-01-15
2001-09-26	0.04	2001-10-15
2001-06-27	0.04	2001-07-16
2001-03-28	0.04	2001-04-16
2000-12-27	0.04	2001-01-15
2000-09-27	0.04	2000-10-15
2000-06-28	0.04	2000-07-15
2000-03-29	0.04	2000-04-15
1999-12-29	0.04	2000-01-14
1999-09-28	0.04	1999-10-15
1999-06-28	0.04	1999-07-15
1999-03-29	0.04	1999-04-15
1998-12-29	0.04	1999-01-15
1998-09-28	0.04	1998-10-15
1998-06-26	0.04	1998-07-15
1998-03-30	0.04	1998-04-15
1997-12-29	0.04	1998-01-15
1997-09-26	0.04	1997-10-15
1997-06-26	0.04	1997-07-15
1997-03-26	0.04	1997-04-15
1996-12-30	0.04	1997-01-15
1996-09-26	0.04	1996-10-15
1996-06-26	0.04	1996-07-15
1996-03-27	0.04	1996-04-15
1995-12-27	0.04	1996-01-15
1995-09-27	0.04	1995-10-13
1995-06-29	0.05	1995-07-14
1995-03-27	0.05	1995-04-13
1994-12-23	0.05	1995-01-13
1994-09-26	0.05	1994-10-14
1994-06-24	0.04	1994-07-15
1994-03-25	0.04	1994-04-15
1993-12-27	0.04	1994-01-14
1993-09-24	0.04	1993-10-15
1993-06-24	0.03	1993-07-15
1993-03-25	0.03	1993-04-15
1992-12-24	0.03	1993-01-15
1992-09-24	0.03	1992-10-15
1992-06-24	0.05	1992-07-15
1992-03-25	0.05	1992-04-15
1991-12-24	0.05	1992-01-15
1991-09-24	0.05	1991-10-15
1991-06-24	0.05	1991-07-15
1991-03-22	0.05	1991-04-15
1990-12-24	0.05	1991-01-15
1990-09-24	0.05	1990-10-15
1990-06-25	0.05	1990-07-16
1989-12-22	0.05	1990-01-15
1989-06-26	0.05	1989-07-17
1988-12-23	0.05	1989-01-16
1988-06-29	0.05	1988-07-15
1987-12-24	0.05	1988-01-15
1987-06-24	0.05	1987-07-15
1986-12-24	0.05	1987-01-15
1986-06-24	0.05	1986-07-15
1985-12-27	0.05	1986-01-15
1985-06-24	0.05	1985-07-19
1984-12-24	0.10	1985-01-15
1984-05-21	0.05	1984-06-13
1983-07-11	0.05	1983-08-12
1981-11-16	1.00	1981-11-13

公司名稱	Viatris Inc Ordinary Shares
行業分類	--
業務描述	Viatris Inc.于2019年2月14日在特拉华州成立。该公司的业务在医药产品的商业化和制造方面处于全球领先地位，拥有20个全球公认的医药品牌以及一个美国的仿制药平台Greenstone。

Viatris Inc Ordinary Shares VTRS 深 滬

10.56

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

Viatris Inc Ordinary Shares VTRS 深滬